News - Ipsen, Roche

Filter

Current filters:

IpsenRoche

Popular Filters

Global neuroendocrine carcinoma market to reach $475 million by 2019; report

04-07-2012

The global Neuroendocrine carcinoma therapeutics market was worth $127 million in 2011 and now the market…

AvastinBioSynthemaIpsenLutatheraMarkets & MarketingOncologyPharmaceuticalRocheSomatuline

Vernalis jumps on deal with Genentech

05-01-2012

The UK's Vernalis (LSE: VER) saw its shares jump more than 5% to 20.75 yesterday, after the company revealed…

FinancialGenentechIpsenLicensingLundbeckPharmaceuticalRocheVernalis

Back to top